![](/img/cover-not-exists.png)
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer
Gustavsson, Bengt, Carlsson, Göran, Swartling, Torbjörn, Kurlberg, Göran, Derwinger, Kristoffer, Björkqvist, Hillevi, Odin, Elisabeth, Gibson, FernandoVolume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0272-0
Date:
October, 2015
File:
PDF, 407 KB
english, 2015